Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases November 2, 2023 Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting October 31, 2023 Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs October 27, 2023 Science Magazine Recognizes Incyte as #2 “Top Employer” of 2023 All press releases Latest Events Nov 30 2023 Nov 30 2023 Evercore ISI HealthCONx Conference Click here for Webcast Nov 7 2023 Nov 7 2023 Guggenheim Securities INI Conference Click here for Webcast Oct 31 2023 Oct 31 2023 Q3 2023 Incyte Corporation Earnings Conference Call Click here for Webcast All events
